HOME >> MEDICINE >> NEWS
Jefferson Lab/Hampton University partnership results in new medical instrumentation center

ing biopsies, has demonstrated a high success rate in pinpointing what is benign and what is malignant.

Both devices rely on injectable solutions of radiopharmaceuticals, which are drugs that are labeled with radioactive isotopes. As the solution circulates throughout the body, it tends to accumulate in malignant cells. The congregated radiopharmaceuticals emit gamma-rays, which are sensed as light by the devices and then converted into electronic signals that can be rendered as a visible image.

"What we will be looking to do is develop minimally invasive instrumentation," Keppel says. "We want to be able to locate and diagnose cancers more effectively. Everything coming out of the Center, at least in the immediate future, will be focused on finding better ways to locate or image those radiopharmaceuticals."

Eastern Virginia Medical School (EVMS) in Norfolk will be joining with CAMI to establish a graduate program in medical physics. It will be the first such program in Virginia, and the first in the country at an historically black college. Any devices resulting from the collaboration will be evaluated both nationally and in clinical programs conducted at Tidewater-area hospitals.

Keppel is in the process of writing proposals that would fund Center personnel in medical physics, engineering and applied technology. In addition to five students and two part-time administrative assistants, Keppel expects up to 10 individuals from Hampton University, the Lab, and EVMS to staff CAMI. "We pool expertise in one place and we get the word out," she says. "The idea is to become an international resource for medical physics and to invite physicians, companies and patient advocacy groups to partner with us."

Groundbreaking for a new CAMI research facility on campus at Hampton University is scheduled for later this spring. When complete in 2003, the Center will enclose 12,000 square feet in two stories, housing primarily research labs
'"/>

Contact: Linda Ware
ware@jlab.org
757-269-7689
DOE/Thomas Jefferson National Accelerator Facility
3-Jul-2002


Page: 1 2 3

Related medicine news :

1. Jefferson Lab medical imager spots breast cancer
2. Jefferson scientists uncover potential trigger of diabetic kidney disease
3. Uric acid may help reduce effects of spinal cord injury, Jefferson researchers find
4. Jefferson scientists help explain statins effects in Alzheimers disease
5. Jefferson scientists find zinc may help prevent esophageal, oral cancers
6. Jefferson virologists coax HIV out of hiding
7. Jefferson scientists find way to see breast cancer activity from outside the body
8. Jefferson and Molecular Targeting Technologies, Inc. scientists create vaccine for wildlife rabies
9. Jefferson scientists use gene therapy to rescue failing hearts in animals
10. Jefferson scientists reveal how some types of rabies invade the brain
11. Jefferson neuroscientists studying new type of Alzheimers drug to halt disease progression

Post Your Comments:
(Date:5/23/2013)... OAK BROOK, Ill. (May 23, 2013) Aortic arch ... a strong independent predictor of disease of the vessels ... new study published in the June issue the journal ... the aortic arch provides functional information about vessel compliance ... disease down the road," said Kevin S. King, M.D., ...
(Date:5/23/2013)... May 23, 2013 During pregnancy both ... are affected by medical treatments, especially medication. In ... Journal of Medicine prompted the FDA to warn about ... birth defects such as persistent pulmonary hypertension and other ... serotonin reuptake inhibitor (SSRI) drugs. SSRI antidepressants are ...
(Date:5/23/2013)... York (PRWEB) May 23, 2013 Maintaining ... today launches its Summer Health Campaign. Kicking off in ... to offering a luxury bed for everyone and to ... overall health and well-being. , May is Better Sleep ... by the Better Sleep Council due to the Centers ...
(Date:5/23/2013)... To kick off barbecue season, fire up the grill ... calories with simple tips from Retrofit weight loss . ... summer. , “The powerful heat of the grill can be ... are not mindful of your selections, it can be as ... Amy Margulies. , Margulies advises clients to choose healthy options ...
(Date:5/23/2013)... 2013 Retül University , the ... announce the formation of a strategic educational partnership with ... to offer a bike industry first “Positioned for Speed” ... for time trial, road and triathlon bike fit. , ... bike fitters with a Retül University, F.I.S.T. or S.I.C.I ...
Breaking Medicine News(10 mins):Health News:MRI-based measurement helps predict vascular disease in the brain 2Health News:Personal Injury Law Firm Releases Graphic with the Latest Information on Antidepressants and a Possible Risk of Birth Defects 2Health News:Personal Injury Law Firm Releases Graphic with the Latest Information on Antidepressants and a Possible Risk of Birth Defects 3Health News:DUXIANA®, Quality Bed Innovator, Celebrates Better Sleep Month and Launches Summer Health Campaign 2Health News:Fire It Up! Master Calories at the Grill with Retrofit Weight Loss 2Health News:Fire It Up! Master Calories at the Grill with Retrofit Weight Loss 3Health News:Retül, Ero Sports and Alphamantis Partner for Industry First Aero Fit Course 2Health News:Retül, Ero Sports and Alphamantis Partner for Industry First Aero Fit Course 3
(Date:5/23/2013)... , May 23, 2013  Intercept Pharmaceuticals, Inc. ... biopharmaceutical company focused on the development and commercialization of ... such as primary biliary cirrhosis, today announced that ... Executive Officer, will present at the Deutsche Bank Securities ... on Wednesday, May 29, 2013 at 4:10 ...
(Date:5/23/2013)... May 23, 2013  MedVantx, Inc., the company that ... channel announced today the Company has completed a major ... in pharmaceutical products and the upgrade of its systems ... facilities in its specialty home delivery pharmacy in ... leading pharmaceutical manufacturers, physicians, health systems and payors novel ...
(Date:5/23/2013)... 23, 2013 InspireMD, Inc. ... leader in embolic protection stents, today announced new ... ST Elevation Reperfusion) trial demonstrating that the MGuard ... drug eluting stents in all-cause mortality in ST ... the trial were presented at the InspireMD STEMI ...
Breaking Medicine Technology:MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 2MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 3InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 2InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 3InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 4InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 5
Cached News: